U.S. FDA says Epix's Vasovist cleared for sale
WASHINGTON (Reuters) - U.S. regulators have approved Epix Pharmaceuticals Inc's Vasovist imaging agent to help detect blood vessel problems, the U.S. Food and Drug Administration said on Wednesday.
Epix, which announced the approval on Monday, has said the injectable product can help doctors better track the flow of blood seen in scans and find blockages or other vessel complications.
The FDA released its decision on its website here
(Editing by Maureen Bavdek)
